HP and type 2 diabetes mellitus: Due to the low survival rate of patients with type 2 diabetes after a cardiovascular incident and the fact that myocardial infarction or stroke of the central nervous system also affects people without known cardiovascular risk factors (dyslipidemia, nicotine use, hypertension), we decided to investigate the relationship between a specific haptoglobin phenotype and the activity of specific markers regulating inflammatory processes (SMRIP) in the body in patients with type 2 diabetes.